DG

Durairaj Gnanaprakasam

Active Director Additional Director DIN 09170919
DIN 09170919 First appointment May 2021 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Durairaj Gnanaprakasam

Data last updated:

Durairaj Gnanaprakasam is an Additional Director at Cellcreep Biotech Private Limited (since 2021). The company operates in Business Services.

DIN 09170919
Primary Designation Additional Director
Industry Business Services
First Appointment 12 May 2021
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cellcreep Biotech Private Limited U74999KA2016PTC096277
Additional Director12 May 20212016Active

Board colleagues of Durairaj Gnanaprakasam

NameDINCompanyDesignation
Ushakumary06434951Cellcreep Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cellcreep Biotech Private Limited
Premium access

Shareholding and investment profile for Durairaj Gnanaprakasam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Durairaj Gnanaprakasam

Durairaj Gnanaprakasam currently holds 1 directorship: Cellcreep Biotech Private Limited (Additional Director, since 12 May 2021).

Durairaj Gnanaprakasam was first appointed on 12 May 2021 as Additional Director at Cellcreep Biotech Private Limited.

The current boards of Durairaj Gnanaprakasam's companies include Ushakumary (Cellcreep Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available